研究者総覧 - 脇口　宏之

ワキグチ　ヒロユキ
脇口　宏之

所属大分大学医学部・委託事業大分こども急性救急疾患学部門医療・研究事業

職種教授

展覧会・演奏会・競技会等
2026	3. Idiopathic inflammatory myopathies (10)/5. Systemic lupus erythematosus (6)/8. Systemic sclerosis (5) TeMPRA: advancing continuing professional development in pediatric rheumatology in Japan
2026	5. Systemic lupus erythematosus (7) Childhood-Onset Systemic Lupus Erythematosus Research over the Past Decade in Japan
2025	1. Kawasaki disease (6) Quantitative serum proteomics to identify candidate biomarkers of coronary artery lesions in Kawasaki disease
2025	2. Food allergy (5) Ultrasonographic findings, including small bowel intussusception, in acute food protein-induced enterocolitis syndrome
2025	2. Food allergy (6) Non-immunoglobulin E-mediated gastrointestinal food allergies in children with Down syndrome: An epidemiological study
2025	3. Idiopathic inflammatory myopathies (9)/5. Systemic lupus erythematosus (5)/8. Systemic sclerosis (3) Vaccination in paediatric, adolescent, and transitional-age rheumatic diseases: A systematic review
2025	8. Systemic sclerosis (4) Clinical improvement of salt-and-pepper skin changes in juvenile systemic sclerosis using mycophenolate mofetil after intravenous methylprednisolone: a 3-year follow-up
2024	7. Cryopyrin-associated periodic syndrome (2) Clinical Characteristics of Cryopyrin-Associated Periodic Syndrome and Long-Term Real-World Efficacy and Tolerability of Canakinumab in Japan: Results of a Nationwide Survey
2023	2. Food allergy (4) Enhanced early skin treatment for atopic dermatitis in infants reduces food allergy
2023	3. Idiopathic inflammatory myopathies (7) Magnetic resonance imaging and pathological findings of fasciitis in anti-PM/Scl antibody-positive juvenile myositis
2023	3. Idiopathic inflammatory myopathies (8)/5. Systemic lupus erythematosus (4)/8. Systemic sclerosis (2) Clinical Features of COVID-19 in Pediatric Rheumatic Diseases: 2020-2022 Survey of the Pediatric Rheumatology Association of Japan
2023	4. Liposteroid therapy (3) Treatment for macrophage activation syndrome associated with systemic juvenile idiopathic arthritis in Japan
2022	2. Food allergy (3) Food Protein-Induced Enterocolitis Syndrome in Children with Down Syndrome: A Pilot Case-Control Study
2022	8. Systemic sclerosis (1) Successful treatment of children with juvenile systemic sclerosis using mycophenolate mofetil after methylprednisolone pulse therapy: A 3-year follow-up
2021	5. Systemic lupus erythematosus (3) Juvenile Neuropsychiatric Systemic Lupus Erythematosus With Magnetic Resonance Imaging Findings Similar to Acute Necrotizing Encephalopathy
2021	6. Blau syndrome (2) A novel mutation in early-onset sarcoidosis/Blau syndrome: an association with Propionibacterium acnes
2020	1. Kawasaki disease (5) Utility of Soluble CD163 in the Clinical Management of Patients With Kawasaki Disease
2019	1. Kawasaki disease (4) Dynamics of immunocyte activation during intravenous immunoglobulin treatment in Kawasaki disease
2019	3. Idiopathic inflammatory myopathies (6) Multispecialty approach for improving outcomes in juvenile dermatomyositis
2019	7. Cryopyrin-associated periodic syndrome (1) Early canakinumab therapy for the sensorineural deafness in a family with Muckle-Wells syndrome due to a novel mutation of NLRP3 gene
2018	2. Food allergy (2) Lobonemoides robustus (jellyfish) anaphylaxis without poly-γ-glutamic acid sensitization
2017	3. Idiopathic inflammatory myopathies (4) Axillary Skin Ulcers in Infants with Juvenile Dermatomyositis
2017	3. Idiopathic inflammatory myopathies (5)/4. Liposteroid therapy (2) Liposteroid therapy for juvenile and adult dermatomyositis: efficacy and side effects
2017	5. Systemic lupus erythematosus (2) Treatable renal disease in children with silent lupus nephritis detected by baseline biopsy: association with serum C3 levels
2017	6. Blau syndrome (1) Tumor Necrosis Factor Inhibitors Provide Longterm Clinical Benefits in Pediatric and Young Adult Patients with Blau Syndrome
2016	1. Kawasaki disease (2) Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin
2016	1. Kawasaki disease(3)/3. Idiopathic inflammatory myopathies (3)/4. Liposteroid therapy (1)/5. Systemic lupus erythematosus (1) Clinical utility of the liposteroid therapy: Potential effects on the macrophage activation
2016	3. Idiopathic inflammatory myopathies (2) Severe gluteal skin ulcers in an infant with juvenile dermatomyositis
2015	1. Kawasaki disease (1) Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease
2015	2. Food allergy (1) Long-lasting non-IgE-mediated gastrointestinal cow's milk allergy in infants with Down syndrome
2015	3. Idiopathic inflammatory myopathies (1) Successful control of juvenile dermatomyositis-associated macrophage activation syndrome and interstitial pneumonia: distinct kinetics of interleukin-6 and -18 levels